Literature DB >> 14966299

Over-expression of FK506-binding protein FKBP12.6 alters excitation-contraction coupling in adult rabbit cardiomyocytes.

C M Loughrey1, T Seidler, S L W Miller, J Prestle, K E MacEachern, D F Reynolds, G Hasenfuss, G L Smith.   

Abstract

This study investigated the function of FK506-binding protein (FKBP12.6) using adenoviral-mediated gene transfer to over-express FKBP12.6 (Ad-FKBP12.6) in adult rabbit ventricular cardiomyocytes. Infection with a beta-galactosidase-expressing adenovirus (Ad-LacZ) was used as a control. Peak-systolic intracellular [Ca(2+)] (measured with Fura-2) was higher in the Ad-FKBP12.6 group compared to Ad-LacZ (1 Hz field stimulation at 37 degrees C). The amplitude of caffeine-induced Ca(2+) release was also greater, indicating a higher SR Ca(2+) content in the Ad-FKBP12.6 group. Voltage clamp experiments indicated that FKBP12.6 over-expression did not change L-type Ca(2+) current amplitude or Ca(2+) efflux rates via the Na(+)-Ca(2+) exchanger. Ca(2+) transients comparable to those after Ad-FKBP12.6 transfection could be obtained by enhancing SR Ca(2+) content of Ad-LacZ infected cells with periods of high frequency stimulation. Line-scan confocal microscopy (Fluo-3 fluorescence) of intact cardiomyocytes stimulated at 0.5 Hz (20-21 degrees C) revealed a higher degree of synchronicity of SR Ca(2+) release and fewer non-responsive Ca(2+) release sites in the Ad-FKBP12.6 group compared to control. Ca(2+) spark morphology was measured in beta-escin-permeabilized cardiomyocytes at a free [Ca(2+)](i) of 150 nm. The average values of the spark parameters (amplitude, duration, width and frequency) were reduced in the Ad-FKBP12.6 group. Increasing [Ca(2+)](i) to 400 nm caused coherent propagating Ca(2+) waves in the Ad-FKBP12.6 group but only limited Ca(2+) release events were recorded in the control group. These data indicate that FKBP12.6 over-expression enhances Ca(2+) transient amplitude predominately by increasing SR Ca(2+) content. Moreover, there is also evidence that FKBP12.6 can enhance the coupling between SR Ca(2+) release sites independently of SR content.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 14966299      PMCID: PMC1665006          DOI: 10.1113/jphysiol.2003.057166

Source DB:  PubMed          Journal:  J Physiol        ISSN: 0022-3751            Impact factor:   5.182


  35 in total

1.  Coupled gating between cardiac calcium release channels (ryanodine receptors).

Authors:  S O Marx; J Gaburjakova; M Gaburjakova; C Henrikson; K Ondrias; A R Marks
Journal:  Circ Res       Date:  2001-06-08       Impact factor: 17.367

2.  PKA phosphorylation dissociates FKBP12.6 from the calcium release channel (ryanodine receptor): defective regulation in failing hearts.

Authors:  S O Marx; S Reiken; Y Hisamatsu; T Jayaraman; D Burkhoff; N Rosemblit; A R Marks
Journal:  Cell       Date:  2000-05-12       Impact factor: 41.582

3.  A comparison of the effects of ATP and tetracaine on spontaneous Ca(2+) release from rat permeabilised cardiac myocytes.

Authors:  G L Smith; S C O'Neill
Journal:  J Physiol       Date:  2001-07-01       Impact factor: 5.182

4.  Role of the transverse-axial tubule system in generating calcium sparks and calcium transients in rat atrial myocytes.

Authors:  Malcolm M Kirk; Leighton T Izu; Ye Chen-Izu; Stacey L McCulle; W Gil Wier; C William Balke; Stephen R Shorofsky
Journal:  J Physiol       Date:  2003-01-31       Impact factor: 5.182

5.  Amplitude distribution of calcium sparks in confocal images: theory and studies with an automatic detection method.

Authors:  H Cheng; L S Song; N Shirokova; A González; E G Lakatta; E Ríos; M D Stern
Journal:  Biophys J       Date:  1999-02       Impact factor: 4.033

6.  Underlying mechanisms of symmetric calcium wave propagation in rat ventricular myocytes.

Authors:  S Subramanian; S Viatchenko-Karpinski; V Lukyanenko; S Györke; T F Wiesner
Journal:  Biophys J       Date:  2001-01       Impact factor: 4.033

7.  Overexpression of FK506-binding protein FKBP12.6 in cardiomyocytes reduces ryanodine receptor-mediated Ca(2+) leak from the sarcoplasmic reticulum and increases contractility.

Authors:  J Prestle; P M Janssen; A P Janssen; O Zeitz; S E Lehnart; L Bruce; G L Smith; G Hasenfuss
Journal:  Circ Res       Date:  2001-02-02       Impact factor: 17.367

8.  FKBP binding characteristics of cardiac microsomes from diverse vertebrates.

Authors:  L H Jeyakumar; L Ballester; D S Cheng; J O McIntyre; P Chang; H E Olivey; L Rollins-Smith; J V Barnett; K Murray; H B Xin; S Fleischer
Journal:  Biochem Biophys Res Commun       Date:  2001-03-09       Impact factor: 3.575

9.  Altered stoichiometry of FKBP12.6 versus ryanodine receptor as a cause of abnormal Ca(2+) leak through ryanodine receptor in heart failure.

Authors:  M Yano; K Ono; T Ohkusa; M Suetsugu; M Kohno; T Hisaoka; S Kobayashi; Y Hisamatsu; T Yamamoto; M Kohno; N Noguchi; S Takasawa; H Okamoto; M Matsuzaki
Journal:  Circulation       Date:  2000-10-24       Impact factor: 29.690

10.  Heterogeneous changes in action potential and intracellular Ca2+ in left ventricular myocyte sub-types from rabbits with heart failure.

Authors:  M A McIntosh; S M Cobbe; G L Smith
Journal:  Cardiovasc Res       Date:  2000-01-14       Impact factor: 10.787

View more
  18 in total

1.  Automated detection of elementary calcium release events using the á trous wavelet transform.

Authors:  F v Wegner; M Both; R H A Fink
Journal:  Biophys J       Date:  2005-12-30       Impact factor: 4.033

2.  Is ryanodine receptor phosphorylation key to the fight or flight response and heart failure?

Authors:  Thomas Eschenhagen
Journal:  J Clin Invest       Date:  2010-11-22       Impact factor: 14.808

Review 3.  Role of ryanodine receptor subtypes in initiation and formation of calcium sparks in arterial smooth muscle: comparison with striated muscle.

Authors:  Kirill Essin; Maik Gollasch
Journal:  J Biomed Biotechnol       Date:  2009-12-08

Review 4.  FK506-binding proteins 12 and 12.6 (FKBPs) as regulators of cardiac Ryanodine Receptors: Insights from new functional and structural knowledge.

Authors:  Luis A Gonano; Peter P Jones
Journal:  Channels (Austin)       Date:  2017-06-21       Impact factor: 2.581

Review 5.  Altered sarcoplasmic reticulum calcium cycling--targets for heart failure therapy.

Authors:  Changwon Kho; Ahyoung Lee; Roger J Hajjar
Journal:  Nat Rev Cardiol       Date:  2012-10-23       Impact factor: 32.419

6.  Sensitized signalling between L-type Ca2+ channels and ryanodine receptors in the absence or inhibition of FKBP12.6 in cardiomyocytes.

Authors:  Yan-Ting Zhao; Yun-Bo Guo; Lei Gu; Xue-Xin Fan; Hua-Qian Yang; Zheng Chen; Peng Zhou; Qi Yuan; Guang-Ju Ji; Shi-Qiang Wang
Journal:  Cardiovasc Res       Date:  2017-03-01       Impact factor: 10.787

7.  Hypoxia enhances high-voltage-activated calcium currents in rat primary cortical neurons via calcineurin.

Authors:  Kun Xiang; Damien Earl; Trisha Dwyer; Brian L Behrle; Elizabeth I Tietz; L John Greenfield
Journal:  Epilepsy Res       Date:  2012-01-13       Impact factor: 3.045

8.  Chronic heart rate reduction with ivabradine improves systolic function of the reperfused heart through a dual mechanism involving a direct mechanical effect and a long-term increase in FKBP12/12.6 expression.

Authors:  Nicolas Couvreur; Renaud Tissier; Sandrine Pons; Valérie Chetboul; Vassiliky Gouni; Patrick Bruneval; Chantal Mandet; Jean-Louis Pouchelon; Alain Berdeaux; Bijan Ghaleh
Journal:  Eur Heart J       Date:  2009-12-21       Impact factor: 29.983

9.  Removal of FKBP12.6 does not alter the conductance and activation of the cardiac ryanodine receptor or the susceptibility to stress-induced ventricular arrhythmias.

Authors:  Jianmin Xiao; Xixi Tian; Peter P Jones; Jeff Bolstad; Huihui Kong; Ruiwu Wang; Lin Zhang; Henry J Duff; Anne M Gillis; Sidney Fleischer; Michael Kotlikoff; Julio A Copello; S R Wayne Chen
Journal:  J Biol Chem       Date:  2007-10-05       Impact factor: 5.157

Review 10.  Ryanodine receptor-mediated arrhythmias and sudden cardiac death.

Authors:  Lynda M Blayney; F Anthony Lai
Journal:  Pharmacol Ther       Date:  2009-04-01       Impact factor: 12.310

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.